[Form 4] Monster Beverage Corp Insider Trading Activity

Rhea-AI Filing Summary

Monster Beverage Corp Chief Commercial Officer reported selling 30,000 shares of common stock on 12/12/2025 at a weighted average price of $73.31 per share, with individual trades executed between $73.29 and $73.37. After this sale and an administrative correction adding 1,232 previously omitted shares, he beneficially owns 63,939 shares directly.

The filing also lists multiple employee stock options and restricted stock units granted under the Monster Beverage Corporation 2020 Omnibus Incentive Plan, covering additional potential common shares at exercise prices between $36.62 and $60.3. These options and restricted stock units vest on various dates from March 12, 2026 through March 14, 2029, providing significant ongoing equity-based compensation.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tirre Emelie

(Last) (First) (Middle)

1 MONSTER WAY

(Street)

CORONA CA 92879

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Monster Beverage Corp [ MNST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/12/2025		S		30,000	D	$73.31(1)	63,939(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$44.47							(3)	03/12/2031	Common Stock	(4)		20,000	D
Employee Stock Option (right to buy)	$36.62							(5)	03/14/2032	Common Stock	(4)		46,000	D
Employee Stock Option (right to buy)	$50.82							(6)	03/14/2033	Common Stock	(4)		19,998	D
Employee Stock Option (right to buy)	$50.82							(7)	03/14/2033	Common Stock	(4)		20,000	D
Employee Stock Option (right to buy)	$60.3							(8)	03/14/2034	Common Stock	(4)		18,000	D
Employee Stock Option (right to buy)	$55.09							(9)	03/14/2035	Common Stock	(4)		21,000	D
Restricted Stock Units	(10)							(11)	(12)	Common Stock	(4)		1,680	D
Restricted Stock Units	(10)							(13)	(12)	Common Stock	(4)		7,480	D
Restricted Stock Units	(10)							(14)	(12)	Common Stock	(4)		5,100	D
Restricted Stock Units	(10)							(15)	(12)	Common Stock	(4)		5,400	D
Restricted Stock Units	(10)							(16)	(12)	Common Stock	(4)		7,000	D

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $73.29 to $73.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

2. This amount reflects the reported transaction and 1,232 additional shares that were inadvertently omitted from the reporting person's most recently filed Form 4 due to an administrative error.

3. The options are currently vested with respect to 14,000 shares. The remaining options vest on March 12, 2026.

4. No transaction is being reported at this time. This line is only reporting holdings as of the date hereof.

5. The options are currently vested with respect to 20,700 shares. The remaining options vest in two installments as follows: 11,500 shares on March 14, 2026 and 13,800 shares on March 14, 2027.

6. The options are currently vested with respect to 5,000 shares. The remaining options vest in three installments as follows: 4,000 shares on March 14, 2026; 5,000 shares on March 14, 2027 and 6,000 shares on March 14, 2028.

7. The options are currently vested with respect to 13,332 shares. The remaining options vest on March 14, 2026.

8. The options are currently vested with respect to 1,800 shares. The remaining options vest in four installments as follows: 2,700 shares on March 14, 2026; 3,600 shares on March 14, 2027; 4,500 shares on March 14, 2028 and 5,400 shares on March 14, 2029.

9. The options vest in four equal installments on March 14, 2026, March 14, 2027, March 14, 2028 and March 14, 2029.

10. The restricted stock units were granted under the Monster Beverage Corporation 2020 Omnibus Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock as of the vesting date.

11. The restricted stock units vest on March 12, 2026.

12. Not applicable.

13. The restricted stock units vest in two installments as follows: 3,400 units on March 14, 2026 and 4,080 units on March 14, 2027.

14. The restricted stock units vest in three installments as follows: 1,360 units on March 14, 2026; 1,700 units on March 14, 2027 and 2,040 units on March 14, 2028.

15. The restricted stock units vest in four installments as follows: 900 units on March 14, 2026; 1,200 units on March 14, 2027; 1,500 units on March 14, 2028 and 1,800 units on March 14, 2029.

16. The restricted stock units vest in four equal installments on March 14, 2026, March 14, 2027, March 14, 2028 and March 14, 2029.

	Paul J. Dechary, attorney-in-fact	12/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Monster Beverage (MNST) report in this filing?

The Chief Commercial Officer of Monster Beverage Corp reported selling 30,000 shares of common stock in a single reported transaction on 12/12/2025.

At what price were the Monster Beverage shares sold by the CCO?

The shares were sold at a weighted average price of $73.31 per share, with individual trade prices ranging from $73.29 to $73.37.

How many Monster Beverage shares does the CCO own after the reported sale?

Following the transaction and an administrative correction for 1,232 previously omitted shares, the Chief Commercial Officer beneficially owns 63,939 shares of Monster Beverage common stock.

What stock options does the Monster Beverage CCO hold according to this report?

The report lists several employee stock options to buy Monster Beverage common stock, including options with exercise prices of $44.47 expiring on 03/12/2031, $36.62 expiring on 03/14/2032, $50.82 expiring on 03/14/2033, $60.3 expiring on 03/14/2034, and $55.09 expiring on 03/14/2035, covering tens of thousands of shares in total.

What restricted stock units (RSUs) are outstanding for the Monster Beverage CCO?

The filing shows multiple restricted stock unit awards under the Monster Beverage Corporation 2020 Omnibus Incentive Plan, including grants covering 1,680, 7,480, 5,100, 5,400, and 7,000 units, each representing a contingent right to receive one share of common stock upon vesting.

When do the Monster Beverage options and RSUs reported here vest?

The explanations state that various option and RSU tranches vest on dates including March 12, 2026 and in installments on March 14, 2026, March 14, 2027, March 14, 2028, and March 14, 2029, depending on the specific grant.